| Product Code: ETC7580028 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 Iran Antimicrobial Resistance Market Overview  | 
3.1 Iran Country Macro Economic Indicators  | 
3.2 Iran Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F  | 
3.3 Iran Antimicrobial Resistance Market - Industry Life Cycle  | 
3.4 Iran Antimicrobial Resistance Market - Porter's Five Forces  | 
3.5 Iran Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F  | 
3.6 Iran Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F  | 
3.7 Iran Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F  | 
3.8 Iran Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F  | 
4 Iran Antimicrobial Resistance Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing prevalence of infectious diseases in Iran  | 
4.2.2 Growing awareness about the importance of antimicrobial resistance  | 
4.2.3 Government initiatives to combat antimicrobial resistance  | 
4.3 Market Restraints  | 
4.3.1 Limited access to healthcare facilities in rural areas  | 
4.3.2 Lack of standardized guidelines for antibiotic use  | 
4.3.3 High cost associated with antimicrobial resistance treatments  | 
5 Iran Antimicrobial Resistance Market Trends  | 
6 Iran Antimicrobial Resistance Market, By Types  | 
6.1 Iran Antimicrobial Resistance Market, By Indication  | 
6.1.1 Overview and Analysis  | 
6.1.2 Iran Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F  | 
6.1.3 Iran Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F  | 
6.1.4 Iran Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F  | 
6.1.5 Iran Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F  | 
6.1.6 Iran Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F  | 
6.1.7 Iran Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F  | 
6.1.8 Iran Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F  | 
6.2 Iran Antimicrobial Resistance Market, By Drug Class  | 
6.2.1 Overview and Analysis  | 
6.2.2 Iran Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F  | 
6.2.3 Iran Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F  | 
6.2.4 Iran Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F  | 
6.2.5 Iran Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F  | 
6.2.6 Iran Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F  | 
6.2.7 Iran Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F  | 
6.3 Iran Antimicrobial Resistance Market, By Mechanism of Action  | 
6.3.1 Overview and Analysis  | 
6.3.2 Iran Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F  | 
6.3.3 Iran Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F  | 
6.3.4 Iran Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F  | 
6.4 Iran Antimicrobial Resistance Market, By Pathogen  | 
6.4.1 Overview and Analysis  | 
6.4.2 Iran Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F  | 
6.4.3 Iran Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F  | 
6.4.4 Iran Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F  | 
6.4.5 Iran Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F  | 
6.4.6 Iran Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F  | 
6.4.7 Iran Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F  | 
7 Iran Antimicrobial Resistance Market Import-Export Trade Statistics  | 
7.1 Iran Antimicrobial Resistance Market Export to Major Countries  | 
7.2 Iran Antimicrobial Resistance Market Imports from Major Countries  | 
8 Iran Antimicrobial Resistance Market Key Performance Indicators  | 
8.1 Percentage of healthcare facilities with antimicrobial stewardship programs  | 
8.2 Number of reported cases of antibiotic-resistant infections  | 
8.3 Rate of adherence to antibiotic prescribing guidelines in healthcare settings  | 
9 Iran Antimicrobial Resistance Market - Opportunity Assessment  | 
9.1 Iran Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F  | 
9.2 Iran Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F  | 
9.3 Iran Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F  | 
9.4 Iran Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F  | 
10 Iran Antimicrobial Resistance Market - Competitive Landscape  | 
10.1 Iran Antimicrobial Resistance Market Revenue Share, By Companies, 2024  | 
10.2 Iran Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |